Oncotherapy Science Inc. (30O)
Market Open
12 Aug, 06:02
XFRA 
€
0. 08
+0.01
+7.0064%
€
35.4M Market Cap
- P/E Ratio
- Div Yield
490 Volume
- Eps
€ 0.08
Previous Close Want to track 30O and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Oncotherapy Science Inc. (30O) Statistics
Valuation metrics
Market Cap 35.4M
Enterprise value -11.48M
Trailing P/E (ttm) -0.03
Forward P/E -
PEG ratio -
Price/Sales (ttm) 0.05
Price/Book (mrq) 3.42
Enterprise Value/Revenue -2.74
Enterprise Value/EBITDA 0.01
Overview
Shares outstanding 338.64M
Float 344.8M
Shares short -
% Held by insiders 0.12%
% Held by institutions 0.01%
Average volume (10 days) 488
Average volume (90 days) 902
Price summary
52-Week low 0.06
52-Week high 0.19
Beta 0.19
50-Day moving average 0.1
200-Day moving average 0.11
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 500:1
Last split Date 26 Sep 2013
Financials
Fiscal year
Fiscal year ends 31 Mar 2025
Most recent quarter (mrq) 31 Mar 2024
Profitability
Profit margin -1.12%
Operating margin -1.32%
Operational effectiveness
Return on assets -0.27%
Return on equity -0.59%
Income Statement
Revenue (ttm) 4.19M
Revenue per share (ttm) 2.6
Quarterly revenue growth (yoy) -0.51%
Gross profit (ttm) -2.6M
EBITDA -
Net income to common (ttm) -4.71M
Diluted EPS (ttm) -0.02
Quarterly earnings growth (yoy) -1%
Balance Sheet
Total cash (mrq) 11.68M
Total cash per share (mrq) 5.8
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 8.53%
Book value per share (mrq) 0.03
Cash Flow
Cash flow statement -813.74M
Levered free cash flow (LFCF) -815.28M
